Conventional metastatic prostate cancer models simply aren’t adequate for many therapeutic evaluations, while novel treatment strategies increasingly rely on the natural activity of living, human immune systems. Humanized mice are far more effective at modeling hormonal and immune therapies.
Join Dr. Steven Kregel, postdoctoral fellow at the University of Michigan’s Chinnaiyan Lab, as he discusses their work establishing a humanized immune system model of metastatic prostate cancer.
Watch this webinar to:
Dr. Steven Kregel is a postdoctoral fellow at the University of Michigan’s Chinnaiyan Lab, which studies basic cancer biology to discover novel biomarkers and therapeutic agents. His own work focuses on the functional and mechanistic development of novel androgen receptor therapeutics and the improved preclinical prostate cancer models.
© 2019 Taconic Biosciences, Inc. All rights reserved.